Lombard Odier Asset Management (Usa) Corp Exact Sciences Corp Transaction History

Lombard Odier Asset Management (Usa) Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $2.24 Million - $2.95 Million	-25,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $1.55 Million - $2.41 Million	25,000 New	25,000 $2.17 Million
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $280,200 - $413,300	-5,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $241,450 - $403,000	5,000 New	5,000 $395,000
Q2 2018 Aug 14, 2018	SELL	$37.84 - $69.96 $3.35 Million - $6.19 Million	-88,526 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $71,476 - $103,266	1,795 Added 2.07%	88,526 $3.57 Million
Q4 2017 Feb 13, 2018	BUY	$46.49 - $60.51 $4.03 Million - $5.25 Million	86,731	86,731 $4.56 Million

674

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.